Automated Author ProfileSavelli, G.
Savelli, G.
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 0.7 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Background: Breast cancer (BC) is the most frequent cancer in European women with nearly 30% of the patients eventually developing metastases. Neuroendocrine differentiation is a rare event, but overexpression of somatostatin receptors in BC has been reported in many studies. Case Report: A patient with liver metastases from BC was treated with peptide receptor radionuclide therapy (PRRT). Computed tomography scan and biochemical examinations showed a clear response to radionuclide therapy. Conclusion: PRRT may be useful in metastatic BC patients.
Authors
- Savelli, G. ;
- Zaniboni, A. ;
- Bertagna, F. ;
- Bosio, G. ;
- Nisa, L. ;
- Rodella, C. ;
- Biasiotto, G. ;
- Bettinsoli, G. ;
- Migliorati, E. ;
- Peli, A.
Background: Breast cancer (BC) is the most frequent cancer in European women with nearly 30% of the patients eventually developing metastases. Neuroendocrine differentiation is a rare event, but overexpression of somatostatin receptors in BC has been reported in many studies. Case Report: A patient with liver metastases from BC was treated with peptide receptor radionuclide therapy (PRRT). Computed tomography scan and biochemical examinations showed a clear response to radionuclide therapy. Conclusion: PRRT may be useful in metastatic BC patients.
Authors
- Savelli, G. ;
- Zaniboni, A. ;
- Bertagna, F. ;
- Bosio, G. ;
- Nisa, L. ;
- Rodella, C. ;
- Biasiotto, G. ;
- Bettinsoli, G. ;
- Migliorati, E. ;
- Peli, A.